ORLANDO, Fla. – There was some drama on the American Affiliation for Most cancers Analysis annual assembly: shares crashed, corporations debuted new compounds and trial outcomes, and a blood most cancers thriller inched nearer to being solved. In the event you missed the convention right here this previous week, listed below are some highlights.
Moderna and Merck confirmed the primary randomized scientific proof that their melanoma vaccine mRNA-4157, together with pembrolizumab, can cut back the chance of relapse for sufferers, in comparison with pembrolizumab alone.
Unlock this text by subscribing to STAT+ and revel in your first 30 days free!
GET STARTED